compensation: Eligible participants in the study will be compensated
employment type: employee's choice
QR Code Link to This Post
For people between 55 and 85 years of age whoa re experiencing Moderately Severe to Severe symptoms of Alzheimer's and not taking Namenda (memantine), there may be help available.
At PRI we're conducting a research study evaluating an investigational medication for moderately severe to severe Alzheimer's disease. Participants and study partner involvement will last 4 to 5 months. Study related medical care and study medication are provided at no cost to qualified study participants. Plus there is compensation available for travel.
Ref #: 892-PRI